Drug types used within a drug rehabilitation patient population with toxicological analysis
Drug
Type
Total
Patients (%)
Amphetamines
Stimulant
30
51
Alcohol
Depressant
26
44
Cannabis
Depressant
22
37
Pregabalin
Depressant
21
36
Benzodiazepines
Depressant
16
27
Opiates/Opioids
Depressant
12
20
Tramadol
Depressant
8
14
Synthetic cannabinoids
Stimulant/Depressant/Hallucinogen
1
2
Declarations
Acknowledgments
The authors acknowledge the support provided by the National Rehabilitation Centre, Abu Dhabi, UAE for the medical and laboratory resources involved in the patient analysis as well as staffing resources for the collation of data and scientific writing of this article. The authors also acknowledge the support provided by Medical University of Lodz for staffing resources related to the conception and scientific writing of this article.
Ojo O, Wang XH, Ojo OO, Ibe J. The effects of substance abuse on blood glucose parameters in patients with diabetes: a systematic review and meta-analysis.Int J Environ Res Public Health. 2018;15:2691. [DOI] [PubMed] [PMC]
Warner EA, Greene GS, Buchsbaum MS, Cooper DS, Robinson BE. Diabetic ketoacidosis associated with cocaine use.Arch Intern Med. 1998;158:1799–802. [DOI] [PubMed]
Sheldon BH, Quin JD. Diabetes and illicit drug use.Pract Diabetes. 2005;22:222–4. [DOI]
Diabetes Australia. Drug use and type 1 diabetes. 2016.
Ng RS, Darko DA, Hillson RM. Street drug use among young patients with type 1 diabetes mellitus in the UK.Diabetic Med. 2004;21:295–6. [DOI] [PubMed]
Johnson KH, Bazargan M, Charpital CJ. Alcohol, tobacco and drug use and the onset of type 2 diabetes mellitus among inner-city minority patients.J Am Board Fam Pract. 2001;14:430–6. [PubMed]
Hicks D. Recreational drugs and their impact on diabetes.J Diabetes Nurs. 2016;20:110–4.
Lewis D, van den Heuvel C, Kenneally M, Byard RW. Methamphetamine use and the risk of diabetic ketoacidosis.Med Sci Law. 2022;62:39–42. [DOI] [PubMed]
Ceriello A, Giugliano D, Dello Russo P, Sgambato S, D’Onofrio F. Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine.Diabetologia. 1982;22:379. [DOI] [PubMed]
Giugliano D. Morphine, opioid peptides, and pancreatic islet function.Diabetes Care. 1984;7:92–8. [DOI] [PubMed]
Yazici ZMC, Bilge B, Bolkent S. Anti-inflammatory potential of delta-9-tetrahydrocannabinol in hyperinsulinemia: an experimental study.Mol Biol Rep. 2022;49:11891–9. [DOI] [PubMed]
Al Ghaferi HA, Ali AY, Gawad TA, Wanigaratne S. Developing substance misuse services in United Arab Emirates: the National Rehabilitation Centre experience.BJPsych Int. 2017;14:92–6. [DOI] [PubMed] [PMC]
Al Ghafri H, Abuelgasim EA, Ali AY, Al Mamari S, Gawad TA, Alawadhi A, et al. A 6-year review of drug trends in the United Arab Emirates from the perspective of the National Rehabilitation Center (NRC) Abu Dhabi.Curr Top Toxicol. 2020;16:151–6.
Roque-Bravo R, Silva RS, Malheiro RF, Carmo H, Carvalho F, da Silva DD, et al. Synthetic cannabinoids: a pharmacological and toxicological overview.Annu Rev Pharmacol Toxicol. 2022;63:187–209. [DOI] [PubMed]
